Can You Share an Ozempic Pen? Why the FDA Says Never
[Drug safety · Injection pens]

Can You Share an Ozempic Pen? Why the FDA Says Never

Ozempic, Wegovy, Mounjaro and Zepbound labels · FDA and CDC on insulin pens · Checked November 21, 2026

Published · By Ethen Amezquita

Short answer: No. Never share an Ozempic pen, or any medicine pen, with anyone, even with a new needle. The Ozempic label says it plainly: do not share your pen with other people, even if the needle has been changed. The Wegovy, Mounjaro and Zepbound labels say the same. The reason is that blood can flow back into the pen during a normal shot, where you can't see it, so the next person's dose can carry it. CDC and FDA have warned about this with insulin pens since 2009.

People ask this for good reasons: a partner on the same medicine, a pen with doses left over, a friend who ran out. The answer is still no. Below is why a new needle doesn't fix it, the exact words on each label, and what happened when insulin pens were shared in hospitals. We read every source on November 21, 2026.

Why a new needle is not enough

A pen holds many doses in one cartridge or reservoir. The needle is the only part you change. CDC explains that blood can flow back into the cartridge after a shot, which means the pen can pass on an infection "even when the needle is changed." CDC's pen handout adds that this backflow can happen during an injection and is invisible to the eye, and its injection guidance says blood may be present in the pen after use.

So the medicine left in the pen may no longer be just medicine. A fresh needle on top doesn't change what is inside. CDC names hepatitis viruses and HIV among the infections that can spread this way.

What the labels say

Each of these labels has a section in Warnings and Precautions titled "Never Share" the pen, and the same rule in the Medication Guide and Instructions for Use that come in the box. All four Medication Guides add: "You may give other people a serious infection, or get a serious infection from them."

PenWhat the label says
Ozempic pen"Do not share your OZEMPIC pen with other people, even if the needle has been changed." Each multi-dose pen is for use by a single patient (section 5.4).
Wegovy FlexTouch"Do not share your WEGOVY pen with other people, even if the needle has been changed." The label says FlexTouch must never be shared between patients (section 5.11).
Mounjaro KwikPen"Do not share your MOUNJARO KwikPen or needles with other people, even if the needle has been changed." Never share between patients, even if the pen needle is changed (section 5.10).
Zepbound KwikPen"Do not share your ZEPBOUND KwikPen or needles with other people, even if the needle has been changed." Never share between patients, even if the pen needle is changed (section 5.10).

For the prescriber, each label gives the same reason: sharing "poses a risk for transmission of blood-borne pathogens," meaning germs carried in blood. The Mounjaro and Zepbound labels also cover vials, and for those the rule is: do not share your needles or syringes with other people.

Two more lines in the Instructions for Use matter here. The Wegovy leaflet says never use a syringe to draw medicine out of your pen, and the Mounjaro and Zepbound KwikPen leaflets say do not move the medicine from the pen into a syringe. Drawing a dose out to give someone else is not a way around the rule.

The same rule for insulin pens

The rule is the same for insulin pens. The Humalog label says its prefilled pens, cartridges and reusable pens "must never be shared between patients, even if the needle is changed."

FDA put out an alert on March 19, 2009 saying insulin pens and cartridges must never be used on more than one patient. On February 25, 2015, FDA required new label warnings against sharing multi-dose diabetes pens, because using one pen on many patients had been linked to infections picked up in health care settings. FDA's own 2015 page is no longer online; the links here go to the summaries kept by AHRQ's Patient Safety Network, a federal site. The Ozempic, Wegovy, Mounjaro and Zepbound warnings above carry that same rule.

What happened in hospitals

The cases CDC has reported happened in health care settings, where staff used one pen on more than one patient. CDC's clinical reminder says reports kept coming after FDA's 2009 alert, including a 2011 incident that required notifying more than 2,000 patients who may have been exposed.

A CDC review of 2012 to 2018 counted 38 events in which groups of patients were told to get tested for bloodborne infections because of how injections were handled by health care staff, with more than 66,748 patients notified in all. Six of those events involved insulin pens used for more than one patient, and all six were in hospitals:

YearStatePatients notified
2013New York716
2013New York1,915
2013North Carolina205
2013New York (suspected)Not listed
2014New York (suspected)4,247
2014Connecticut3,149

The review lists no infections linked to these six events. The notices went out because of the risk, not because anyone was known to be infected. That is the point: once a pen is shared, nobody can tell what is in it, so everyone exposed gets offered a test. CDC calls using an insulin pen for more than one person a "never event."

What this means for you

  • One pen, one person. That includes a partner or family member on the same medicine, and a pen with doses left over.
  • If two people in your home use the same kind of pen, keep them apart and mark each with a name. CDC asks clinics to label pens with the person's name for the same reason.
  • Don't draw medicine out of a pen into a syringe for someone else. The labels say not to.
  • Use a new needle for every shot, even on your own pen. Our guide to using an injection pen covers needles, storage and disposal.
  • If you already shared a pen, don't panic, and talk with your clinician. When a pen is reused in a clinic or hospital, CDC says the people exposed should be told and offered blood tests for bloodborne infections. Your clinician can tell you if testing makes sense for you.

If you track your shots, log which pen each dose came from. Our guide to tracking doses and side effects shows what to write down.


Frequently asked questions

Can you share an Ozempic pen if you change the needle?+
No. The Ozempic label says never share your pen with other people, even if the needle has been changed. The Wegovy, Mounjaro and Zepbound labels say the same about their pens.
Why isn't a new needle enough?+
CDC explains that blood can flow back into the pen during or after a shot. You can't see it. The next person's dose can then carry that blood, even through a brand-new needle.
Can two people in the same house share a Mounjaro or Zepbound pen?+
No. The labels say do not share your pen with other people, and that includes a partner or family member who takes the same medicine. Each person needs their own pen.
Does the same rule apply to insulin pens?+
Yes. Insulin pen labels such as Humalog say pens must never be shared between patients, even if the needle is changed. FDA and CDC have warned about insulin pen sharing since 2009.
What should I do if I already shared a pen?+
Stop sharing and talk with your clinician. When a pen was reused in a clinic or hospital, CDC says the people exposed should be told and offered blood tests for bloodborne infections.

Sources

Every fact in this article comes from one of these sources, checked on November 21, 2026. This article is for education. It is not medical advice, and nothing here is a dose recommendation.

  1. Ozempic (semaglutide) injection label, Medication Guide and Instructions for Use, Novo Nordisk. DailyMed
  2. Wegovy (semaglutide) label, Medication Guide and FlexTouch Instructions for Use, Novo Nordisk. DailyMed
  3. Mounjaro (tirzepatide) label, Medication Guide and KwikPen Instructions for Use, Eli Lilly. DailyMed
  4. Zepbound (tirzepatide) label, Medication Guide and KwikPen Instructions for Use, Eli Lilly. DailyMed
  5. Humalog (insulin lispro) label, Eli Lilly, section 5.1. DailyMed
  6. U.S. Food and Drug Administration. FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients. FDA Safety Communication, February 25, 2015. Summary on AHRQ Patient Safety Network. psnet.ahrq.gov
  7. U.S. Food and Drug Administration. Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens. March 19, 2009. Summary on AHRQ Patient Safety Network. psnet.ahrq.gov
  8. Centers for Disease Control and Prevention. CDC Clinical Reminder: Insulin Pens Must Never Be Used for More than One Person. 2012. stacks.cdc.gov
  9. Centers for Disease Control and Prevention. Insulin Pens: What Every Healthcare Provider Needs To Know. cdc.gov
  10. Centers for Disease Control and Prevention. Considerations for Blood Glucose Monitoring and Insulin Administration. August 7, 2024. cdc.gov
  11. Schaefer MK, Perkins KM, Perz JF (CDC). Patient notification events due to syringe reuse and mishandling of injectable medications by health care personnel, United States, 2012-2018. Mayo Clin Proc. 2020;95(2):243-254. stacks.cdc.gov